InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Rummelt Andreas, Director. Director active across 2 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 2 filings have been published. History available since 20 May 2021. The latest transaction was disclosed on 21 July 2021 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rummelt Andreas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
28,109 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000064:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000045:0
2 of 2 declarations
About Rummelt Andreas
Andreas Rummelt is a Board Member at Alexion Pharmaceuticals, Inc., a company specializing in innovative therapies for rare diseases. As a board member, he participates in the governance of the company and in shaping its strategy. His expertise in the pharmaceutical sector is a valuable asset for Alexion in its mission to improve patients' lives.
